Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
With a market cap of 871.6B, Eli Lilly(LLY) trades at $929.78. The stock has a price-to-earnings ratio of 40.50 and currently yields dividends of 67.0%.
During the trading session on 2026-04-14, Eli Lilly(LLY) shares reached a daily high of $939.93 and a low of $917.02. At a current price of $929.78, the stock is +1.4% higher than the low and still -1.1% under the high.
Trading volume for Eli Lilly(LLY) stock has reached 2.35M, versus its average volume of 2.84M.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.
LLY News
AbbVie's (ABBV +0.66%) most important therapeutic area has historically been immunology, where it has marketed billion-dollar drugs like Humira, which was once...
A study of analyst recommendations at the major brokerages shows that Johnson & Johnson (Symbol: JNJ) is the #10 broker pick, on average, out of the 30 stocks m...
CrossBridge Bio, a privately held biotech focused on developing cancer drugs, announced on Tuesday an agreement to be acquired by Eli Lilly (LLY) in an all-cash...
Analyst ratings
83%
of 35 ratingsMore LLY News
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All...
Eli Lilly's Jaypirca (pirtobrutinib) achieved positive Phase 3 results in chronic lymphocytic leukemia and small lymphocytic lymphoma. The late stage trial sho...
Denmark-based Novo Nordisk (NVO) is expanding beyond blockbuster drugs like Wegovy with a new partnership with OpenAI. The collaboration aims to use AI to speed...
Eli Lilly (LLY) announced that it has made significant progress with a new leukemia drug, giving its stock a shot in the arm as a result. Unlock hedge fund-lev...
Key Points A weight loss pill would help Eli Lilly reach a broader segment of the population. Its existing GLP-1 drugs have already been generating billions i...
Eli Lilly and Co. (NYSE:LLY) shares were little changed in Monday’s premarket session. The U.S. drug giant shared results from the Phase 3 BRUIN CLL-322 trial...
Eli Lilly (LLY) announced topline results from the Phase 3 BRUIN CLL-322 trial of Jaypirca, a non-covalent Bruton tyrosine kinase inhibitor, plus venetoclax and...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.